351 Rouse Boulevard located in Philadelphia's Navy Yard is the first phase of a microresearch campus for Adaptimmune. The building houses a manufacturing facility and includes lab and office spaces which support Adaptimmune’s clinical development and initial commercialization of novel engineered immunotherapies for cancer. The building is clad in custom architectural precast concrete panels that appear to compress and spiral into the surrounding landscape. The project was designed and constructed under an aggressive schedule and required extensive site improvements
The repetitive module of the structural precast spandrel panels has been subverted through the application of a customized pattern that brings life and texture to the facade. This building received a LEED-Gold certification.
Architectural precast concrete satisfied many of the high-performance requirements on this project: Its strength and durability made it an ideal solution to withstand the heavy use of vehicular traffic, to resist the corrosive effects of vehicular exhaust and jet fuel fumes, and to provide blast resistance in the airport environment. Precast cladding allowed efficient construction scheduling. The General Contractor was able to construct the building structure as the precast fabricator was creating the spandrels, accelerating the schedule. On-time delivery allowed erection to occur with minimal disruption of the construction site. Architectural precast panels offered excellent value, comprising around 5% of the total construction cost and allowed the design team to capitalize on BIM's modeling and sharing capabilities to create a truly unique and expressive design.